Ticker
ABT

Price
108.09
Stock movement up
+0.16 (0.15%)
Company name
Abbott Laboratories
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
189.26B
Ent value
-
Price/Sales
4.16
Price/Book
-
Div yield
1.74%
Div growth
12.14%
Growth years
8
FCF payout
51.80%
Trailing P/E
22.13
Forward P/E
22.85
PEG
1.92
EPS growth
12.40%
1 year return
-14.72%
3 year return
8.55%
5 year return
14.23%
10 year return
13.31%
Last updated: 2022-12-05

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.88
Dividend yield1.74%
Payout frequencyQuarterly
Maximum yield2.29%
Average yield1.65%
Minimum yield1.29%
Discount to avg yield5.20%
Upside potential5.48%
Yield as % of max yield75.88%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield1.74%
Current yield distribution30.00%
Yield at 100% (Min)1.29%
Yield at 90%1.45%
Yield at 80%1.50%
Yield at 50% (Median)1.64%
Yield at 20%1.80%
Yield at 10%1.87%
Yield at 0% (Max)2.29%

Dividend per share

Loading...
Dividend per share data
Years of growth8 years
CCC statusDividend Challenger
Dividend per share1.88
Payout frequencyQuarterly
Ex-div date13 Oct 2022
EPS (TTM)-
EPS (1y forward)4.73
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
ABTS&P500
DGR MR4.44%1.24%
DGR TTM4.44%9.08%
DGR 3 years13.67%3.88%
DGR 5 years12.14%4.73%
DGR 10 years6.93%8.30%
DGR 15 years7.82%5.82%
Time since last change announced361 days
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM28.42%51.80%
Average--
Forward39.75%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E22.13
Price to OCF24.16
Price to FCF40.33
Price to EBITDA27.77
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.16
Price to Book-
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count1.75B
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)45.55B
Gross profit (TTM)26.44B
Operating income (TTM)10.21B
Net income (TTM)8.55B
EPS (TTM)-
EPS (1y forward)4.73

Margins

Loading...
Margins data
Gross margin (TTM)58.05%
Operating margin (TTM)22.42%
Profit margin (TTM)18.78%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash7.67B
Net receivables7.18B
Total current assets23.43B
Goodwill23.18B
Intangible assets12.22B
Property, plant and equipment19.52B
Total assets74.01B
Accounts payable4.76B
Short/Current long term debt17.09B
Total current liabilities12.65B
Total liabilities38.38B
Shareholder's equity0.00
Net tangible assets8.64B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)7.83B
Capital expenditures (TTM)1.40B
Free cash flow (TTM)4.69B
Dividends paid (TTM)2.43B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open106.75
Daily high108.14
Daily low106.20
Daily Volume4.94M
All-time high141.46
1y analyst estimate129.02
Beta0.74
EPS (TTM)-
Dividend per share1.88
Ex-div date13 Oct 2022
Next earnings date24 Jan 2023

Downside potential

Loading...
Downside potential data
ABTS&P500
Current price drop from All-time high-23.59%-14.82%
Highest price drop-46.27%-56.47%
Date of highest drop23 Jul 20029 Mar 2009
Avg drop from high-11.43%-11.46%
Avg time to new high19 days13 days
Max time to new high1275 days1805 days
COMPANY DETAILS
ABT (Abbott Laboratories) company logo
Marketcap
189.26B
Marketcap category
Large-cap
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Employees
113000
SEC filings
CEO
Robert Ford
Country
USA
City
Abbott Park
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
With a price-to-earnings (or "P/E") ratio of 24x Abbott Laboratories ( NYSE:ABT ) may be sending very bearish signals...
December 4, 2022
In this article, we talk about 10 long-term stock picks in billionaire Ray Dalio’s portfolio. If you want to see more stocks in this selection, check out Billionaire Ray Dalio’s 5 Long-Term Stock Pick...
December 2, 2022
Abbott (ABT) closed at $107.93 in the latest trading session, marking a +0.33% move from the prior day.
December 1, 2022
Yahoo Finance health care reporter Anjalee Khemlani shares the latest on the ongoing baby formula shortage and how it may extend into spring 2023.
December 1, 2022
If you want to know who really controls Abbott Laboratories ( NYSE:ABT ), then you'll have to look at the makeup of its...
November 30, 2022
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
November 28, 2022
In this article, we will be taking a look at the 25 countries with highest fertility rates. To skip our detailed analysis, you can go directly to see 10 Countries With Highest Fertility Rates. Being a...
November 28, 2022
In this article, we discuss 11 best diabetes stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Diabetes Stocks To Buy Now. The global diabetes market is segmented b...
November 27, 2022
With a price-to-earnings (or "P/E") ratio of 23.7x Abbott Laboratories ( NYSE:ABT ) may be sending very bearish signals...
November 26, 2022
In this article, we discuss 11 best COVID stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best COVID Stocks To Buy According To Hedge Funds. In Ma...
November 25, 2022
Next page